1997;33(14):2326 -32. 60. Paz-Ares L, Horn L, Borghaei H, Spigel DR, Steins M, Ready N, et al. Phase III , randomized trial (CheckMa te 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non - squamous cell (non -SQ) non -small cell lung cancer (NSCLC). J Clin Oncol 33; 2015 (suppl; abstr LBA109).